In this article, we report a case of clinically severe PE following RFA surgically treated with extracorporeal membrane oxygenation (ECMO).
In a meta-analysis including 8,223 patients, only three patients had PE and none of them was lifethreatening.[6] However, O'Donnell et al.[7] investigated thrombotic complications in varicose vein treatment in a real-world setting and concluded that the number of PE could be underestimated than those reported in clinical trials.
A total of 5 to 10% of all PE cases after varicose vein surgery have an unstable hemodynamic condition, leading to shock and these patients have a 15 to 60%-times higher mortality rate, compared to those with a stable condition.[8] According to the guidelines, in patients with suspected PE presenting with shock or hypotension, if CT angiography reveals positive PE imaging, thrombolysis, surgical embolectomy or catheter-directed treatment modalities can be performed.[9] Moreover, ECMO bridging and pulmonary embolectomy can be life-saving interventions in high-risk PE cases.[10] With the use of CPR and ECMO, thrombolysis can induce bleeding and worsen the clinical situation. In more stable patients, thrombolysis is an effective method to lyse the thrombus in the pulmonary artery with improved clinical status in varicose vein surgery.[11] However, in the literature, such patients were discharged from hospital after the operation and PE usually developed between the postoperative second and fifth days during the home rest. In our case, PE developed very early, 12 h after the operation.
In conclusion, early recognition of deep vein thrombosis and pulmonary embolism and prompt treatment can be life-saving and reduce potential death events. In addition, all sorts of venous interventions should be performed in or in close of the cardiovascular centers, including non-invasive lab procedures.
Declaration of conflicting interests
The authors declared no conflicts of interest with respect to
the authorship and/or publication of this article.
Funding
The authors received no financial support for the research
and/or authorship of this article.
1) Hamdan A. Management of varicose veins and venous
insufficiency. JAMA 2012;308:2612-21.
2) Lurie F, Creton D, Eklof B, Kabnick LS, Kistner RL, Pichot
O, et al. Prospective randomized study of endovenous
radiofrequency obliteration (closure procedure) versus
ligation and stripping in a selected patient population
(EVOLVeS Study). J Vasc Surg 2003;38:207-14.
3) Malgor RD, Gasparis AP, Labropoulos N. Morbidity
and mortality after thermal venous ablations. Int Angiol
2016;35:57-61.
4) Newman JE, Meecham L, Walker RJ, Nyamekye IK.
Optimising treatment parameters for Radiofrequency
Induced Thermal Therapy (RFiTT): A comparison of the
manufacturer's treatment guidance with a locally developed
treatment protocol. Eur J Vasc Endovasc Surg 2014;47:664-9.
5) Benarroch-Gampel J, Sheffield KM, Boyd CA, Riall TS,
Killewich LA. Analysis of venous thromboembolic events
after saphenous ablation. J Vasc Surg Venous Lymphat
Disord 2013;1:26-32.
6) Healy DA, Kimura S, Power D, Elhaj A, Abdeldaim Y, Cross
KS, et al. A systematic review and meta-analysis of thrombotic
events following endovenous thermal ablation of the great
saphenous vein. Eur J Vasc Endovasc Surg 2018;56:410-24.
7) O"Donnell TF, Eaddy M, Raju A, Boswell K, Wright D.
Assessment of thrombotic adverse events and treatment
patterns associated with varicose vein treatment. J Vasc Surg
Venous Lymphat Disord 2015;3:27-34.
8) Marshall PS, Mathews KS, Siegel MD. Diagnosis and
management of life-threatening pulmonary embolism. J
Intensive Care Med 2011;26:275-94.
9) Konstantinides SV, Torbicki A, Agnelli G, Danchin N,
Fitzmaurice D, Galiè N, et al. 2014 ESC guidelines on the
diagnosis and management of acute pulmonary embolism.
Eur Heart J 2014;35:3033-69.